What is the first-line management for uncomplicated superficial folliculitis?

First-Line Management for Uncomplicated Superficial Folliculitis

For uncomplicated superficial folliculitis, topical benzoyl peroxide is the recommended first-line nonantibiotic treatment, with topical mupirocin or clindamycin as first-line antibiotic alternatives if needed. 1

Initial Approach

Simple folliculitis is typically self-limited and often resolves without intervention. 1 The key distinction is that folliculitis involves superficial inflammation where pus is limited to the epidermis, unlike furuncles where suppuration extends into subcutaneous tissue. 2

Treatment Algorithm

First-Line Options:

• Topical benzoyl peroxide as the initial nonantibiotic treatment 1
• Topical mupirocin as a first-line antibiotic option 1
• Topical clindamycin as an alternative first-line antibiotic 1

When to Escalate to Oral Antibiotics:

For treatment-resistant cases that fail topical therapy:

• Oral cephalexin is an appropriate option 1
• Oral dicloxacillin is an appropriate alternative 1

Important Clinical Distinctions

Do not confuse superficial folliculitis with deeper infections: Furuncles and carbuncles require different management (incision and drainage), whereas superficial folliculitis does not. 2 Furuncles are inflammatory nodules with suppuration extending through the dermis into subcutaneous tissue, clinically appearing as nodules with overlying pustules through which hair emerges. 2

Common Pitfalls to Avoid

• Avoid routine cultures for uncomplicated superficial folliculitis—these are not recommended and add unnecessary cost without changing management. 2
• Do not immediately prescribe systemic antibiotics for simple cases, as most are self-limited and respond to topical therapy. 1
• Consider MRSA coverage only if the infection has not improved with initial treatment, as community-acquired MRSA is now common but should not drive initial empiric therapy for superficial disease. 1, 3

When Systemic Antibiotics Are Indicated

Reserve oral antibiotics for:

• Multiple lesions affecting large body surface areas 1
• Treatment failure with topical agents 1
• Household outbreaks requiring rapid control 1
• Presence of systemic signs (fever, tachycardia, elevated white blood cell count) 2